Available IPD datapackage for study 'A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB023 (Anti-TWEAK) Administered to Subjects With Rheumatoid Arthritis.'

Name: Available IPD datapackage for study 'A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB023 (Anti-TWEAK) Administered to Subjects With Rheumatoid Arthritis.'
Creator: Vivli
Published: 2025-07-07 14:40:03
License: 暂无描述

DataCite Commons2025-07-07 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/dataPackages/PR00007173.0

下载链接

链接失效反馈

官方服务：

资源简介：

Phase I study designed to determine the safety and tolerability of a single dose of BIIB023 administered intravenously versus placebo to subjects with RA.

提供机构：

Vivli

创建时间：

2025-07-07